Cargando…
Lack of Durable Cross-Neutralizing Antibodies Against Zika Virus from Dengue Virus Infection
Cross-reactive antibodies elicited by dengue virus (DENV) infection might affect Zika virus infection and confound serologic tests. Recent data demonstrate neutralization of Zika virus by monoclonal antibodies or human serum collected early after DENV infection. Whether this finding is true in late...
Autores principales: | Collins, Matthew H., McGowan, Eileen, Jadi, Ramesh, Young, Ellen, Lopez, Cesar A., Baric, Ralph S., Lazear, Helen M., de Silva, Aravinda M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5403059/ https://www.ncbi.nlm.nih.gov/pubmed/28418292 http://dx.doi.org/10.3201/eid2305.161630 |
Ejemplares similares
-
Role of Zika Virus Envelope Protein Domain III as a Target of Human Neutralizing Antibodies
por: Gallichotte, Emily N., et al.
Publicado: (2019) -
In Vitro Assembly and Stabilization of Dengue and Zika Virus Envelope Protein Homo-Dimers
por: Metz, Stefan W., et al.
Publicado: (2017) -
Dengue Virus Envelope Dimer Epitope Monoclonal Antibodies Isolated from Dengue Patients Are Protective against Zika Virus
por: Swanstrom, J. A., et al.
Publicado: (2016) -
Natural Strain Variation and Antibody Neutralization of Dengue Serotype 3 Viruses
por: Wahala, Wahala M. P. B., et al.
Publicado: (2010) -
Defining levels of dengue virus serotype-specific neutralizing antibodies induced by a live attenuated tetravalent dengue vaccine (TAK-003)
por: White, Laura J., et al.
Publicado: (2021)